

News & Insights
News & Insights
June 2024
Fierce Pharma
“In a 5-4 ideologically scrambled opinion, the court ruled that a bankruptcy settlement that proposed a release of all claims and future litigation against the owners of Purdue Pharma, who had not filed for bankruptcy themselves, was a bridge too far under the bankruptcy code,” John Richer from law firm Hall Estil said in written commentary on Thursday.